Treatment success rate: previously treated TB cases in Upper-middle income (World Bank)
Upper-middle income (World Bank): Treatment success rate: previously treated TB cases was 62 in 2023. ▼ Falling
Latest (2023)
62
Change on year
up 6.9%
Rank
8th
of 11 groups
All-time high
92
in 1995
All-time low
58
in 2022
Years of data
29
1995–2023
Treatment success rate: previously treated TB cases in Upper-middle income (World Bank), 1995–2023
Source: World Health Organization, Global Health Observatory.
Analysis
In 2023, treatment success rate: previously treated tb cases in Upper-middle income (World Bank) stood at 62.
Compared with earlier readings it is up 6.9% on the previous year and down 1.6% over ten years.
Over the whole period, treatment success rate: previously treated tb cases in Upper-middle income (World Bank) peaked at 92 in 1995 and was at its lowest, 58, in 2022.
The long-run direction has been consistently falling across the 29 years of available data.
Treatment success rate: previously treated TB cases in Upper-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 1995 | 92 | — |
| 1996 | 92 | +0.0% |
| 1997 | 70 | -23.9% |
| 1998 | 91 | +30.0% |
| 1999 | 69 | -24.2% |
| 2000 | 71 | +2.9% |
| 2001 | 67 | -5.6% |
| 2002 | 73 | +9.0% |
| 2003 | 75 | +2.7% |
| 2004 | 74 | -1.3% |
| 2005 | 72 | -2.7% |
| 2006 | 70 | -2.8% |
| 2007 | 71 | +1.4% |
| 2008 | 71 | +0.0% |
| 2009 | 70 | -1.4% |
| 2010 | 59 | -15.7% |
| 2011 | 70 | +18.6% |
| 2012 | 65 | -7.1% |
| 2013 | 63 | -3.1% |
| 2014 | 63 | +0.0% |
| 2015 | 62 | -1.6% |
| 2016 | 61 | -1.6% |
| 2017 | 61 | +0.0% |
| 2018 | 61 | +0.0% |
| 2019 | 64 | +4.9% |
| 2020 | 66 | +3.1% |
| 2021 | 63 | -4.5% |
| 2022 | 58 | -7.9% |
| 2023 | 62 | +6.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 82.8 | 69 | 92 | 5 |
| 2000s | 71.4 | 67 | 75 | 10 |
| 2010s | 62.9 | 59 | 70 | 10 |
| 2020s | 62.25 | 58 | 66 | 4 |
More health data for Upper-middle income (World Bank)
- Pertussis - number of reported cases, gaps filled 63,803 (2025)
- Total tetanus - number of reported cases, gaps filled 5,773 (2025)
- Diphtheria - number of reported cases, gaps filled 1,556 (2025)
- Measles - number of reported cases, gaps filled 91,627 (2025)
- Measles - number of reported cases, annual growth rate -27.52 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -87.69 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 10.32 % change on previous year (2025)
- Diphtheria - number of reported cases 1,556 (2025)
- Total tetanus - number of reported cases 5,773 (2025)
- Pertussis - number of reported cases 63,803 (2025)
Frequently asked questions
- What is treatment success rate: previously treated tb cases in Upper-middle income (World Bank)?
- Treatment success rate: previously treated tb cases in Upper-middle income (World Bank) was 62 in 2023, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate: previously treated tb cases recorded in Upper-middle income (World Bank)?
- The highest recorded value was 92 in 1995.
- What is the lowest treatment success rate: previously treated tb cases recorded in Upper-middle income (World Bank)?
- The lowest recorded value was 58 in 2022.
- How does Upper-middle income (World Bank) rank for treatment success rate: previously treated tb cases?
- Upper-middle income (World Bank) ranks 8th out of 11 groups with data for 2023.
- Is treatment success rate: previously treated tb cases rising or falling in Upper-middle income (World Bank)?
- Over the last ten years it is down 1.6%. The long-run trend across the full record is falling.
- Where does this Upper-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate: previously treated TB cases. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 29 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).